Literature DB >> 3782490

New micro method for deoxyuridine suppression test.

A C Petty, J F Burman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3782490      PMCID: PMC500242          DOI: 10.1136/jcp.39.10.1155

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  9 in total

1.  EFFECT OF DEOXYURIDINE ON INCORPORATION OF TRITIATED THYMIDINE: DIFFERENCE BETWEEN NORMOBLASTS AND MEGALOBLASTS.

Authors:  S A KILLMANN
Journal:  Acta Med Scand       Date:  1964-04

2.  INVESTIGATIONS INTO THE EUGLENA METHOD FOR THE ASSAY OF THE VITAMIN B12 IN SERUM.

Authors:  B B ANDERSON
Journal:  J Clin Pathol       Date:  1964-01       Impact factor: 3.411

3.  Results of three years' experience with the deoxyuridine suppression test.

Authors:  S N Wickramasinghe; J E Saunders
Journal:  Acta Haematol       Date:  1977       Impact factor: 2.195

4.  Deranged DNA synthesis by bone marrow from vitamin B-12-deficient humans.

Authors:  J Metz; A Kelly; V C Swett; S Waxman; V Herbert
Journal:  Br J Haematol       Date:  1968-06       Impact factor: 6.998

5.  Automation of the assay of folate in serum and whole blood.

Authors:  L Millbank; R E Davis; M Rawlins; A H Waters
Journal:  J Clin Pathol       Date:  1970-02       Impact factor: 3.411

6.  A fault in the design of the deoxyuridine suppression test.

Authors:  S N Wickramasinghe; J E Saunders
Journal:  Clin Lab Haematol       Date:  1979

7.  Simplifying lymphocyte culture and the deoxyuridine suppression test by using whole blood (0.1 mL) instead of separated lymphocytes.

Authors:  K C Das; C Manusselis; V Herbert
Journal:  Clin Chem       Date:  1980-01       Impact factor: 8.327

8.  Assessment of deoxyuridine suppression test in diagnosis of vitamin B12 or folate deficiency.

Authors:  S N Wickramasinghe; J E Longland
Journal:  Br Med J       Date:  1974-07-20

9.  Megaloblastic haemopoiesis in patients receiving nitrous oxide.

Authors:  J A Amess; J F Burman; G M Rees; D G Nancekievill; D L Mollin
Journal:  Lancet       Date:  1978-08-12       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.